NYSEArca - Nasdaq Real Time Price USD

iShares Genomics Immunology and Healthcare ETF (IDNA)

21.95 +0.01 (+0.07%)
As of 9:37 AM EDT. Market Open.

Top 10 Holdings (42.27% of Total Assets)

SymbolCompany% Assets
SRPT
Sarepta Therapeutics, Inc. 5.39%
MRNA
Moderna, Inc. 4.69%
RVMD
Revolution Medicines, Inc. 4.63%
MRK
Merck & Co., Inc. 4.48%
GSK.L
GSK plc 4.16%
REGN
Regeneron Pharmaceuticals, Inc. 4.15%
EXEL
Exelixis, Inc. 3.80%
INCY
Incyte Corporation 3.71%
SAN.PA
Sanofi 3.68%
IOVA
Iovance Biotherapeutics, Inc. 3.57%

Sector Weightings

SectorIDNA
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Overall Portfolio Composition (%)

Stocks 99.81%
Bonds 0.00%

Equity Holdings

Price/Earnings 0
Price/Book 0.35
Price/Sales 0.19
Price/Cashflow 0
Median Market Cap --
3 Year Earnings Growth --

Bond Ratings

US Government 0.00%
AAA --
AA --
A --
BBB --
BB --
B --
Below B --
Other --

ETF Summary

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.

ETF Overview

Category Health
Fund Family iShares
Net Assets 140.9M
YTD Daily Total Return -4.65%
Yield 1.00%
Legal Type Exchange Traded Fund

Related Tickers